Krystal Biotech Statistics
Total Valuation
KRYS has a market cap or net worth of $5.07 billion. The enterprise value is $4.54 billion.
| Market Cap | 5.07B |
| Enterprise Value | 4.54B |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, before market open.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KRYS has 28.56 million shares outstanding. The number of shares has increased by 13.92% in one year.
| Shares Outstanding | 28.56M |
| Shares Change (YoY) | +13.92% |
| Shares Change (QoQ) | +1.52% |
| Owned by Insiders (%) | 12.67% |
| Owned by Institutions (%) | 94.81% |
| Float | 21.04M |
Valuation Ratios
The trailing PE ratio is 94.47 and the forward PE ratio is 66.68.
| PE Ratio | 94.47 |
| Forward PE | 66.68 |
| PS Ratio | 52.86 |
| Forward PS | 16.33 |
| PB Ratio | 6.35 |
| P/FCF Ratio | 111.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 69.84, with an EV/FCF ratio of 99.69.
| EV / Earnings | 79.46 |
| EV / Sales | 47.34 |
| EV / EBITDA | 69.84 |
| EV / EBIT | 76.82 |
| EV / FCF | 99.69 |
Financial Position
The company has a current ratio of 12.66, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.66 |
| Quick Ratio | 12.29 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.17 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.70% and return on invested capital (ROIC) is -8.10%.
| Return on Equity (ROE) | 7.70% |
| Return on Assets (ROA) | 7.30% |
| Return on Capital (ROIC) | -8.10% |
| Revenue Per Employee | $418,991 |
| Profits Per Employee | $249,611 |
| Employee Count | 229 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KRYS has paid $1.97 million in taxes.
| Income Tax | 1.97M |
| Effective Tax Rate | 3.32% |
Stock Price Statistics
The stock price has increased by +51.95% in the last 52 weeks. The beta is 0.89, so KRYS's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | +51.95% |
| 50-Day Moving Average | 166.53 |
| 200-Day Moving Average | 138.43 |
| Relative Strength Index (RSI) | 54.74 |
| Average Volume (20 Days) | 679,372 |
Short Selling Information
The latest short interest is 2.90 million, so 10.16% of the outstanding shares have been sold short.
| Short Interest | 2.90M |
| Short Previous Month | 2.69M |
| Short % of Shares Out | 10.16% |
| Short % of Float | 13.79% |
| Short Ratio (days to cover) | 8.95 |
Income Statement
In the last 12 months, KRYS had revenue of $95.95 million and earned $57.16 million in profits. Earnings per share was $1.88.
| Revenue | 95.95M |
| Gross Profit | 90.44M |
| Operating Income | -67.59M |
| Pretax Income | 59.13M |
| Net Income | 57.16M |
| EBITDA | 65.04M |
| EBIT | 59.13M |
| Earnings Per Share (EPS) | $1.88 |
Balance Sheet
The company has $538.26 million in cash and $7.90 million in debt, giving a net cash position of $530.36 million or $18.57 per share.
| Cash & Cash Equivalents | 538.26M |
| Total Debt | 7.90M |
| Net Cash | 530.36M |
| Net Cash Per Share | $18.57 |
| Equity (Book Value) | 799.24M |
| Book Value Per Share | 27.99 |
| Working Capital | 554.66M |
Cash Flow
In the last 12 months, operating cash flow was -$46.76 million and capital expenditures $92.32 million, giving a free cash flow of $45.56 million.
| Operating Cash Flow | -46.76M |
| Capital Expenditures | 92.32M |
| Free Cash Flow | 45.56M |
| FCF Per Share | $1.61 |
Margins
Gross margin is 94.25%, with operating and profit margins of -70.44% and 59.57%.
| Gross Margin | 94.25% |
| Operating Margin | -70.44% |
| Pretax Margin | 61.62% |
| Profit Margin | 59.57% |
| EBITDA Margin | 67.78% |
| EBIT Margin | 61.62% |
| FCF Margin | 47.49% |
Dividends & Yields
KRYS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.92% |
| Shareholder Yield | -13.92% |
| Earnings Yield | 1.13% |
| FCF Yield | 0.90% |
Analyst Forecast
The average price target for KRYS is $175.67, which is -1.09% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $175.67 |
| Price Target Difference | -1.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 79.83% |
| EPS Growth Forecast (5Y) | 106.82% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRYS has an Altman Z-Score of 56.98 and a Piotroski F-Score of 4.
| Altman Z-Score | 56.98 |
| Piotroski F-Score | 4 |